• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

1990 年至 2017 年药物使用障碍发病率趋势:基于 2017 年全球疾病负担数据的分析。

Trends of the incidence of drug use disorders from 1990 to 2017: an analysis based on the Global Burden of Disease 2017 data.

机构信息

Clinical Research Center, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China.

School of Public Health, Xi'an Jiaotong University Health Science Center, Xi'an, Shaanxi, China.

出版信息

Epidemiol Psychiatr Sci. 2020 Aug 4;29:e148. doi: 10.1017/S2045796020000657.

DOI:10.1017/S2045796020000657
PMID:32746958
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7443796/
Abstract

AIM

Drug use disorders are an important issue worldwide. Systematic attempts to estimate the global incidence of drug use disorders are rare. We aimed to determine the incidence of drug use disorders and their trends.

METHODS

We obtained the annual incident cases and age-standardised incidence rate (ASR) of drug use disorders from 1990 to 2017 using the Global Health Data Exchange query tool. The estimated annual percentage changes of the ASR were used to quantify and evaluate the trends in the incidence rate. Gaussian process regression and the Pearson's correlation coefficient were used to assess the relationship between the ASR and socio-demographic index (SDI).

RESULTS

The number of drug use disorders' cases increased by 33.5% from 1990 to 2017 globally, whereas the ASR exhibited a stable trend. The ASR was higher in men than in women. Most cases (53.1%) of drug use disorders involved opioid. A positive association (ρ=0.35, p < 0.001) was found between ASR and SDI. Teenagers aged 15-19 years had the highest incidence rate.

CONCLUSIONS

The incident cases of drug use disorders were increasing, but the incidence rate did not change significantly from 1990 to 2017. Current preventive measures and policies for drug use disorders might have little effect. The present results suggest that future strategies should focus on men, teenagers and high-risk regions in order to improve the current status of drug use disorders.

摘要

目的

药物使用障碍是一个全球性的重要问题。系统地估计全球药物使用障碍的发病率是罕见的。我们旨在确定药物使用障碍的发病率及其趋势。

方法

我们使用全球卫生数据交换查询工具从 1990 年到 2017 年获得了药物使用障碍的年度发病病例和年龄标准化发病率(ASR)。使用估计的年百分比变化来量化和评估发病率的趋势。高斯过程回归和 Pearson 相关系数用于评估 ASR 与社会人口指数(SDI)之间的关系。

结果

全球范围内,1990 年至 2017 年药物使用障碍的病例数增加了 33.5%,而 ASR 呈稳定趋势。男性的 ASR 高于女性。大多数药物使用障碍病例(53.1%)涉及阿片类药物。ASR 与 SDI 之间存在正相关关系(ρ=0.35,p<0.001)。15-19 岁的青少年发病率最高。

结论

药物使用障碍的发病病例在增加,但从 1990 年到 2017 年,发病率没有明显变化。目前针对药物使用障碍的预防措施和政策可能效果不大。目前的结果表明,未来的策略应侧重于男性、青少年和高风险地区,以改善药物使用障碍的现状。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/78ea/7443796/d102311515aa/S2045796020000657_fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/78ea/7443796/5982f3c8d38e/S2045796020000657_fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/78ea/7443796/c4496598fd67/S2045796020000657_fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/78ea/7443796/649ae369dd2f/S2045796020000657_fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/78ea/7443796/d102311515aa/S2045796020000657_fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/78ea/7443796/5982f3c8d38e/S2045796020000657_fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/78ea/7443796/c4496598fd67/S2045796020000657_fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/78ea/7443796/649ae369dd2f/S2045796020000657_fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/78ea/7443796/d102311515aa/S2045796020000657_fig4.jpg

相似文献

1
Trends of the incidence of drug use disorders from 1990 to 2017: an analysis based on the Global Burden of Disease 2017 data.1990 年至 2017 年药物使用障碍发病率趋势:基于 2017 年全球疾病负担数据的分析。
Epidemiol Psychiatr Sci. 2020 Aug 4;29:e148. doi: 10.1017/S2045796020000657.
2
Global burden of myocarditis in youth and middle age (1990-2019): A systematic analysis of the disease burden and thirty-year forecast.全球青年和中年人心肌炎负担(1990-2019 年):疾病负担的系统分析及 30 年预测。
Curr Probl Cardiol. 2024 Sep;49(9):102735. doi: 10.1016/j.cpcardiol.2024.102735. Epub 2024 Jun 29.
3
Incidence trend of five common musculoskeletal disorders from 1990 to 2017 at the global, regional and national level: results from the global burden of disease study 2017.1990 年至 2017 年全球、区域和国家层面五种常见肌肉骨骼疾病的发病趋势:2017 年全球疾病负担研究结果。
Ann Rheum Dis. 2020 Aug;79(8):1014-1022. doi: 10.1136/annrheumdis-2020-217050. Epub 2020 May 15.
4
Global burden of pelvic inflammatory disease and ectopic pregnancy from 1990 to 2019.全球 1990 年至 2019 年盆腔炎性疾病和异位妊娠负担。
BMC Public Health. 2023 Oct 2;23(1):1894. doi: 10.1186/s12889-023-16663-y.
5
Global, regional and national burden of non-Hodgkin lymphoma from 1990 to 2017: estimates from global burden of disease study in 2017.全球、区域和国家非霍奇金淋巴瘤负担:2017 年全球疾病负担研究估计。
Ann Med. 2022 Dec;54(1):633-645. doi: 10.1080/07853890.2022.2039957.
6
Global, regional, and national burden of brain and other CNS cancer, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016.全球、区域和国家脑和其他中枢神经系统癌症负担,1990-2016 年:2016 年全球疾病负担研究的系统分析。
Lancet Neurol. 2019 Apr;18(4):376-393. doi: 10.1016/S1474-4422(18)30468-X. Epub 2019 Feb 21.
7
Trends in the incidence and DALYs of schizophrenia at the global, regional and national levels: results from the Global Burden of Disease Study 2017.全球、区域和国家层面精神分裂症发病率和伤残调整寿命年趋势:来自 2017 年全球疾病负担研究的结果。
Epidemiol Psychiatr Sci. 2020 Jan 13;29:e91. doi: 10.1017/S2045796019000891.
8
The trends in incidence of primary liver cancer caused by specific etiologies: Results from the Global Burden of Disease Study 2016 and implications for liver cancer prevention.特定病因引起的原发性肝癌发病率趋势:2016 年全球疾病负担研究结果及其对肝癌预防的意义。
J Hepatol. 2019 Apr;70(4):674-683. doi: 10.1016/j.jhep.2018.12.001. Epub 2018 Dec 11.
9
Global, regional, and national burden of Hodgkin lymphoma from 1990 to 2017: estimates from the 2017 Global Burden of Disease study.全球、区域和国家霍奇金淋巴瘤负担:2017 年全球疾病负担研究估计。
J Hematol Oncol. 2019 Oct 22;12(1):107. doi: 10.1186/s13045-019-0799-1.
10
The global, regional, and national burden of inflammatory bowel disease in 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017.195 个国家和地区 1990-2017 年炎症性肠病的全球、区域和国家负担:2017 年全球疾病负担研究的系统分析。
Lancet Gastroenterol Hepatol. 2020 Jan;5(1):17-30. doi: 10.1016/S2468-1253(19)30333-4. Epub 2019 Oct 21.

引用本文的文献

1
Burden of opioid use disorder in the Middle East and North Africa (MENA): findings from Global Burden of Disease (GBD) study.中东和北非地区阿片类物质使用障碍的负担:全球疾病负担(GBD)研究的结果
J Health Popul Nutr. 2025 Aug 18;44(1):296. doi: 10.1186/s41043-025-01029-4.
2
Global burden on drug use disorders from 1990 to 2021 and projections to 2046.1990年至2021年药物使用障碍的全球负担及到2046年的预测。
Front Public Health. 2025 Jul 28;13:1550518. doi: 10.3389/fpubh.2025.1550518. eCollection 2025.
3
Global, regional, and national trends and burden of opioid use disorder in individuals aged 15 years and above: 1990 to 2021 and projections to 2040.

本文引用的文献

1
Targeting Youth to Prevent Later Substance Use Disorder: An Underutilized Response to the US Opioid Crisis.针对青年预防后期物质使用障碍:美国阿片类药物危机的一种未充分利用的应对措施。
Am J Public Health. 2019 Jun;109(S3):S185-S189. doi: 10.2105/AJPH.2019.305020.
2
Using Census Data to Understand County-Level Differences in Overall Drug Mortality and Opioid-Related Mortality by Opioid Type.利用人口普查数据了解县一级总体药物死亡率和阿片类药物相关死亡率在阿片类药物类型方面的差异。
Am J Public Health. 2019 Aug;109(8):1084-1091. doi: 10.2105/AJPH.2019.305136. Epub 2019 Jun 20.
3
Cannabis use in youth is associated with limited alterations in brain structure.
15岁及以上人群阿片类物质使用障碍的全球、区域和国家趋势及负担:1990年至2021年及2040年预测
Epidemiol Psychiatr Sci. 2025 Jun 13;34:e32. doi: 10.1017/S2045796025100085.
4
Burden of Substance Use Disorders in the Middle East and North Africa from 1990 to 2019.1990年至2019年中东和北非地区物质使用障碍负担
Balkan Med J. 2025 Mar 3;42(2):138-149. doi: 10.4274/balkanmedj.galenos.2025.2024-11-61.
5
Global burden of drug use disorders by region and country, 1990-2021.全球药物使用障碍负担按区域和国家划分,1990-2021 年。
Front Public Health. 2024 Oct 29;12:1470809. doi: 10.3389/fpubh.2024.1470809. eCollection 2024.
6
Global burden and cross-country inequalities in stroke and subtypes attributable to diet from 1990 to 2019.全球范围内 1990 年至 2019 年饮食导致的卒中及其亚型的疾病负担和国家间差异。
BMC Public Health. 2024 Jul 8;24(1):1813. doi: 10.1186/s12889-024-19337-5.
7
The global burden of cataracts and its attributable risk factors in 204 countries and territories: a systematic analysis of the global burden of disease study.全球 204 个国家和地区白内障的全球负担及其归因风险因素:全球疾病负担研究的系统分析。
Front Public Health. 2024 Jun 12;12:1366677. doi: 10.3389/fpubh.2024.1366677. eCollection 2024.
8
Burden of drug use disorders in the United States from 1990 to 2021 and its projection until 2035: results from the GBD study.1990 年至 2021 年美国药物使用障碍负担及其至 2035 年的预测:来自 GBD 研究的结果。
BMC Public Health. 2024 Jun 19;24(1):1639. doi: 10.1186/s12889-024-19142-0.
9
Association between socioeconomic and motherhood characteristics with receiving community-based treatment services among justice-involved young female drug users: a retrospective cohort study in Taiwan.社会经济和母亲特征与涉法年轻女性吸毒者接受社区治疗服务之间的关联:一项在台湾的回顾性队列研究。
Harm Reduct J. 2024 Jun 5;21(1):109. doi: 10.1186/s12954-024-01010-0.
10
Neurobiological mechanisms and related clinical treatment of addiction: a review.成瘾的神经生物学机制及相关临床治疗:综述
Psychoradiology. 2022 Dec 16;2(4):180-189. doi: 10.1093/psyrad/kkac021. eCollection 2022 Dec.
青少年吸食大麻与大脑结构的有限改变有关。
Neuropsychopharmacology. 2019 Jul;44(8):1362-1369. doi: 10.1038/s41386-019-0347-2. Epub 2019 Feb 19.
4
Association between nonmedical use of opioids or sedatives and suicidal behavior among Chinese adolescents: An analysis of sex differences.阿片类药物或镇静剂的非医疗使用与中国青少年自杀行为之间的关联:性别差异分析。
Aust N Z J Psychiatry. 2019 Jun;53(6):559-569. doi: 10.1177/0004867418814944. Epub 2018 Dec 10.
5
Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017.全球、区域和国家层面 195 个国家和地区 1990 年至 2017 年 354 种疾病和伤害导致的发病率、患病率和伤残损失寿命年:基于 2017 年全球疾病负担研究的系统分析。
Lancet. 2018 Nov 10;392(10159):1789-1858. doi: 10.1016/S0140-6736(18)32279-7. Epub 2018 Nov 8.
6
The global burden of disease attributable to alcohol and drug use in 195 countries and territories, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016.1990 - 2016年195个国家和地区因酒精和药物使用所致的全球疾病负担:全球疾病负担研究2016的系统分析
Lancet Psychiatry. 2018 Dec;5(12):987-1012. doi: 10.1016/S2215-0366(18)30337-7. Epub 2018 Nov 1.
7
Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016.全球、区域和国家发病率、患病率以及 195 个国家和地区 1990 年至 2016 年 328 种疾病和伤害导致的残疾年数:2016 年全球疾病负担研究的系统分析。
Lancet. 2017 Sep 16;390(10100):1211-1259. doi: 10.1016/S0140-6736(17)32154-2.
8
Adverse Effects of Cannabis on Adolescent Brain Development: A Longitudinal Study.大麻对青少年大脑发育的不良影响:一项纵向研究。
Cereb Cortex. 2017 Mar 1;27(3):1922-1930. doi: 10.1093/cercor/bhw015.
9
Cannabis use and mania symptoms: a systematic review and meta-analysis.大麻使用与躁狂症状:一项系统评价与荟萃分析。
J Affect Disord. 2015 Jan 15;171:39-47. doi: 10.1016/j.jad.2014.09.016. Epub 2014 Sep 23.
10
Early-age clinical and developmental features associated to Substance Use Disorders in Attention-Deficit/Hyperactivity Disorder in Adults.成人注意力缺陷/多动障碍中与物质使用障碍相关的早期临床和发育特征。
Compr Psychiatry. 2014 Apr;55(3):639-49. doi: 10.1016/j.comppsych.2013.12.002. Epub 2013 Dec 10.